SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-099115
Filing Date
2023-12-28
Accepted
2023-12-28 11:30:10
Documents
14
Period of Report
2023-12-28
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea190815-8k_pasithea.htm   iXBRL 8-K 33321
2 CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED CERTIFICATE OF INCORPORATIO ea190815ex3-1_pasithea.htm EX-3.1 9696
  Complete submission text file 0001213900-23-099115.txt   268536

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ktta-20231228.xsd EX-101.SCH 3810
4 XBRL DEFINITION FILE ktta-20231228_def.xml EX-101.DEF 26681
5 XBRL LABEL FILE ktta-20231228_lab.xml EX-101.LAB 36819
6 XBRL PRESENTATION FILE ktta-20231228_pre.xml EX-101.PRE 25305
8 EXTRACTED XBRL INSTANCE DOCUMENT ea190815-8k_pasithea_htm.xml XML 5536
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40804 | Film No.: 231520799
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)